We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

U:NYSEUnity Software Inc. Analysis

Data as of 2026-05-06 - not real-time

$27.28

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Unity Software is trading in a neutral technical environment with bullish momentum signals, including a positive MACD crossover and an RSI in the upper‑mid range, suggesting continued short‑term upside. Recent news of a raised revenue outlook and strong performance from its Vector business have reinforced investor sentiment, driving a multi‑day rally that outperformed the broader market. Fundamentally, the company shows strong cash generation and a solid balance sheet, but profitability remains negative and operating margins are under pressure.
The current price sits just below a key resistance level and above short‑term support, offering a tactical entry point for traders, while the valuation appears roughly aligned with intrinsic estimates, leaving limited upside beyond the next resistance. Long‑term investors may find the platform’s AI‑enabled tools and expanding ecosystem compelling, provided they can tolerate the high volatility and beta inherent to a high‑growth tech stock.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 8/10

Key Factors

  • Positive MACD histogram and bullish crossover
  • Higher revenue guidance boosting sentiment
  • Price positioned above short‑term support with room to test resistance

Medium Term

1–3 years
Neutral
Model confidence: 7/10

Key Factors

  • Mixed valuation signals versus intrinsic fair value
  • Elevated volatility and beta indicating price swings
  • Strong cash position offsetting operating losses

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • Strategic foothold in real‑time 3D and AI‑driven development tools
  • Expanding addressable market across gaming, enterprise, and XR
  • Robust balance sheet providing runway for continued investment

Key Metrics & Analysis

Financial Health

Revenue Growth10.10%
Profit Margin-21.77%
P/E Ratio21.5
ROE-11.60%
ROA-4.34%
Debt/Equity66.49
P/B Ratio3.6
Op. Cash Flow$423.0M
Free Cash Flow$550.8M
Industry P/E37.2

Technical Analysis

TrendNeutral
RSI63.9
Support$20.88
Resistance$28.25
MA 20$25.49
MA 50$22.17
MA 200$34.36
MACDBullish
VolumeDecreasing
Fear & Greed Index90.38

Valuation

Fair Value$25.06
Target Price$31.97
Upside/Downside17.21%
GradeFair
TypeGrowth

Risk Assessment

Beta2.35
Volatility63.68%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.